186 related articles for article (PubMed ID: 33707516)
21. Role of body condition score and adiponectin expression in the progression of canine mammary carcinomas.
Tesi M; Millanta F; Poli A; Mazzetti G; Pasquini A; Panzani D; Rota A; Vannozzi I
Vet Med Sci; 2020 Aug; 6(3):265-271. PubMed ID: 32202386
[TBL] [Abstract][Full Text] [Related]
22. Relationship between major histocompatibility complex class I expression and prognosis in canine mammary gland tumors.
Tanaka T; Shimada T; Akiyoshi H; Shimizu J; Zheng C; Yijyun L; Mie K; Hayashi A; Kuwamura M; Hoshi F; Ohashi F
J Vet Med Sci; 2013 Oct; 75(10):1393-8. PubMed ID: 23728200
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases.
Rasotto R; Berlato D; Goldschmidt MH; Zappulli V
Vet Pathol; 2017 Jul; 54(4):571-578. PubMed ID: 28355108
[TBL] [Abstract][Full Text] [Related]
24. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
25. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical demonstration of metallothionein in benign and malignant canine mammary tumours.
Fuentealba IC; Mullins JE
Histol Histopathol; 1999 Jan; 14(1):51-61. PubMed ID: 9987650
[TBL] [Abstract][Full Text] [Related]
27. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
28. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.
Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD
Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of canine mammary tumours on the Canary Archipelago in Spain.
Rodríguez J; Santana Á; Herráez P; Killick DR; de Los Monteros AE
BMC Vet Res; 2022 Jul; 18(1):268. PubMed ID: 35821034
[TBL] [Abstract][Full Text] [Related]
30. Comparison between ultrasonographic findings of benign and malignant canine mammary gland tumours using B-mode, colour Doppler, power Doppler and spectral Doppler.
Soler M; Dominguez E; Lucas X; Novellas R; Gomes-Coelho KV; Espada Y; Agut A
Res Vet Sci; 2016 Aug; 107():141-146. PubMed ID: 27473987
[TBL] [Abstract][Full Text] [Related]
31. P-cadherin expression in canine mammary tissues.
Gama A; Paredes J; Albergaria A; Gartner F; Schmitt F
J Comp Pathol; 2004 Jan; 130(1):13-20. PubMed ID: 14693120
[TBL] [Abstract][Full Text] [Related]
32. Identification of potential canine mammary tumour cell biomarkers using proteomic approach: Differences in protein profiles among tumour and normal mammary epithelial cells by two-dimensional electrophoresis-based mass spectrometry.
Fhaikrue I; Srisawat W; Nambooppha B; Pringproa K; Thongtharb A; Prachasilchai W; Sthitmatee N
Vet Comp Oncol; 2020 Dec; 18(4):787-795. PubMed ID: 32421920
[TBL] [Abstract][Full Text] [Related]
33. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
[TBL] [Abstract][Full Text] [Related]
34. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.
Manuali E; De Giuseppe A; Feliziani F; Forti K; Casciari C; Marchesi MC; Pacifico E; Pawłowski KM; Majchrzak K; Król M
BMC Vet Res; 2012 Jun; 8():86. PubMed ID: 22726603
[TBL] [Abstract][Full Text] [Related]
35. Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.
Santos M; Correia-Gomes C; Santos A; de Matos A; Rocha E; Lopes C; Pereira PD
Vet J; 2014 Jun; 200(3):426-33. PubMed ID: 24745769
[TBL] [Abstract][Full Text] [Related]
36. Solid Carcinoma of the Canine Mammary Gland: a Histological Type or Tumour Cell Arrangement?
Nakagaki KY; Nunes MM; Garcia APV; Nunes FC; Schmitt F; Cassali GD
J Comp Pathol; 2022 Jan; 190():1-12. PubMed ID: 35152966
[TBL] [Abstract][Full Text] [Related]
37. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
[TBL] [Abstract][Full Text] [Related]
38. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
39. Catechol-o-methyltransferase genotypes are associated with progression and biological behaviour of canine mammary tumours.
Canadas A; Santos M; Pinto R; Medeiros R; Dias-Pereira P
Vet Comp Oncol; 2018 Dec; 16(4):664-669. PubMed ID: 30168237
[TBL] [Abstract][Full Text] [Related]
40. Decorin concentrations in canine normal and neoplastic mammary gland tissues.
Szczubiał M; Kankofer M; Wawrzykowski J; Dąbrowski R; Łopuszyński W; Bochniarz M; Brodzki P
Reprod Domest Anim; 2020 Oct; 55(10):1404-1410. PubMed ID: 33470009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]